← Back to Search

Brachytherapy

Experimental: Intra-operative Radiation Therapy - IORT for Breast Cancer

N/A
Waitlist Available
Led By A. M. Nisar Syed, MD
Research Sponsored by Xoft, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up reported at 5 years
Awards & highlights

Study Summary

This trial is testing whether a new type of radiation therapy, called IORT, is better than the current standard of care, whole breast irradiation (WBI), for women with early stage breast cancer.

Eligible Conditions
  • Breast Cancer
  • Ductal Carcinoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~reported at 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and reported at 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assess the rate of ipsilateral breast tumor recurrence (IBTR) at 5 years

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental: Intra-operative Radiation Therapy - IORTExperimental Treatment1 Intervention
Intra-operative Radiation Therapy

Find a Location

Who is running the clinical trial?

Xoft, Inc.Lead Sponsor
10 Previous Clinical Trials
2,487 Total Patients Enrolled
3 Trials studying Breast Cancer
182 Patients Enrolled for Breast Cancer
Icad, Inc.Industry Sponsor
4 Previous Clinical Trials
1,348 Total Patients Enrolled
A. M. Nisar Syed, MDPrincipal InvestigatorLong Beach Memorial Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Dec 2033